Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The developmental moisturizing cream-GlaxoSmithKline refers to a set of experimental topical cosmetic formulations developed by GSK's consumer healthcare division. These creams are designed to improve skin barrier function and provide intensive moisturization for individuals with dry and sensitive skin. In clinical proof-of-concept studies, the formulations were evaluated for their ability to reduce transepidermal water loss (TEWL) and increase skin hydration (corneometry) on the face and legs over a four-week period. Unlike pharmaceutical drugs, these products are classified as cosmetics and function primarily through physical and chemical properties that support the stratum corneum, rather than through specific biological targets or active pharmaceutical ingredients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on developmental moisturizing cream-GlaxoSmithKline.